Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Amortization of Deferred Charges (2018 - 2025)

Health Catalyst (HCAT) has disclosed Amortization of Deferred Charges for 8 consecutive years, with $817000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization of Deferred Charges fell 38.06% year-over-year to $817000.0, compared with a TTM value of $4.1 million through Sep 2025, up 66.22%, and an annual FY2024 reading of $3.3 million, up 115.49% over the prior year.
  • Amortization of Deferred Charges was $817000.0 for Q3 2025 at Health Catalyst, down from $881000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $3.1 million in Q4 2021 and bottomed at $374000.0 in Q1 2022.
  • Average Amortization of Deferred Charges over 5 years is $1.1 million, with a median of $380000.0 recorded in 2024.
  • The sharpest move saw Amortization of Deferred Charges soared 907.02% in 2021, then tumbled 87.89% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $3.1 million in 2021, then crashed by 87.89% to $376000.0 in 2022, then rose by 0.8% to $379000.0 in 2023, then skyrocketed by 210.82% to $1.2 million in 2024, then plummeted by 30.65% to $817000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for HCAT at $817000.0 in Q3 2025, $881000.0 in Q2 2025, and $1.2 million in Q1 2025.